1. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994; 4:368–381.
Article
2. Ha YC. Epidemiology of osteoporosis in Korea. J Korean Med Assoc. 2016; 59:836–841.
Article
3. Park CH, Lee YK, Ha YC. Change of bone mineral density measurement among patients with osteoporotic fractures in Korean population using national claim database. J Bone Metab. 2017; 24:183–186.
Article
4. Yoon BH, Yu W. Clinical utility of biochemical marker of bone turnover: fracture risk prediction and bone healing. J Bone Metab. 2018; 25:73–78.
Article
5. Hoshino H, Kushida K, Takahashi M, et al. Changes in levels of biochemical markers and ultrasound indices of Os calcis across the menopausal transition. Osteoporos Int. 2000; 11:128–133.
Article
6. Garnero P, Hausherr E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res. 1996; 11:1531–1538.
Article
7. Emami A, Larsson A, Petrén-Mallmin M, et al. Serum bone markers after intramedullary fixed tibial fractures. Clin Orthop Relat Res. 1999; (368):220–229.
Article
8. Orum O, Hansen M, Jensen CH, et al. Procollagen type I N-terminal propeptide (PINP) as an indicator of type I collagen metabolism: ELISA development, reference interval, and hypovitaminosis D induced hyperparathyroidism. Bone. 1996; 19:157–163.
Article
9. Vasikaran S, Cooper C, Eastell R, et al. International osteoporosis foundation and international federation of clinical chemistry and laboratory medicine position on bone marker standards in osteoporosis. Clin Chem Lab Med. 2011; 49:1271–1274.
Article
10. Ivaska KK, Gerdhem P, Väänänen HK, et al. Bone turnover markers and prediction of fracture: a prospective follow-up study of 1040 elderly women for a mean of 9 years. J Bone Miner Res. 2010; 25:393–403.
Article
11. Ardawi MS, Maimani AA, Bahksh TA, et al. Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study. Bone. 2010; 47:804–814.
Article
12. Jenkins N, Black M, Paul E, et al. Age-related reference intervals for bone turnover markers from an Australian reference population. Bone. 2013; 55:271–276.
Article
13. Morovat A, Catchpole A, Meurisse A, et al. IDS iSYS automated intact procollagen-1-N-terminus pro-peptide assay: method evaluation and reference intervals in adults and children. Clin Chem Lab Med. 2013; 51:2009–2018.
Article
14. Brandt J, Krogh TN, Jensen CH, et al. Thermal instability of the trimeric structure of the N-terminal propeptide of human procollagen type I in relation to assay technology. Clin Chem. 1999; 45:47–53.
Article
15. Clinical and Laboratory Standards Institute. Evaluation of precision of quantitative measurement procedures: Approved guideline. 3rd ed. Wayne, PA: CLSI document EP5-A3;2014.
16. Clinical and Laboratory Standards Institute. Evaluation of detection capability for clinical laboratory measurement procedures: Approved guideline. 2nd ed. Wayne, PA: CLSI document EP17-A2;2012.
17. Bauer DC, Sklarin PM, Stone KL, et al. Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures. J Bone Miner Res. 1999; 14:1404–1410.
Article
18. Bauer DC, Garnero P, Harrison SL, et al. Biochemical markers of bone turnover, hip bone loss, and fracture in older men: the MrOS study. J Bone Miner Res. 2009; 24:2032–2038.
Article
19. Finnes TE, Lofthus CM, Meyer HE, et al. Procollagen type 1 amino-terminal propeptide (P1NP) and risk of hip fractures in elderly Norwegian men and women. A NOREPOS study. Bone. 2014; 64:1–7.
Article
20. Garnero P, Vergnaud P, Hoyle N. Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis. Clin Chem. 2008; 54:188–196.
Article
21. Koivula MK, Richardson J, Leino A, et al. Validation of an automated intact N-terminal propeptide of type I procollagen (PINP) assay. Clin Biochem. 2010; 43:1453–1457.
Article
22. Hu WW, Zhang Z, He JW, et al. Establishing reference intervals for bone turnover markers in the healthy Shanghai population and the relationship with bone mineral density in postmenopausal women. Int J Endocrinol. 2013; 2013:513925.
Article
23. Martínez J, Olmos JM, Hernández JL, et al. Bone turnover markers in Spanish postmenopausal women: the Camargo cohort study. Clin Chim Acta. 2009; 409:70–74.
24. Glover SJ, Gall M, Schoenborn-Kellenberger O, et al. Establishing a reference interval for bone turnover markers in 637 healthy, young, premenopausal women from the United Kingdom, France, Belgium, and the United States. J Bone Miner Res. 2009; 24:389–397.
Article